Brii Biosciences Limited Current Assets

As of the most recent data (June 2026), BRIBF shows a current assets of $1.8B. That compares with $2.1B in the prior-year period — down 14.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BRIBF's current assets is now $1.8B (was $2.1B) — a 14.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Brii Biosciences Limited is outperforming or lagging.

Tracking BRIBF's current assets over time shows whether Brii Biosciences Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8B That compares with $2.1B in the prior-year period — down 14.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Brii Biosciences Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $1.8B) with ownership activity and broader fundamentals.

Brii Biosciences Limited's current assets is $1.8B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.